Indegene acquires WARN & Co, expands life sciences consulting practice

Indegene Limited announced on October 17, 2025, the expansion of its consulting practice, aiming to enhance its strategy and transformation expertise for life sciences organizations. This move integrates Indegene's strategic insights with hands-on transformation implementation support to meet the evolving needs of the life sciences industry. The company also named Gobin Chandra as head of the integrated consulting practice.

Further bolstering its consulting capabilities, Indegene Ireland Limited, a wholly-owned subsidiary, signed a share purchase agreement on October 16, 2025, to acquire 100% equity shares in WARN & Co Limited, a UK-based transformation consulting firm. This all-cash transaction involves a total purchase consideration not exceeding £3 million, subject to net working capital adjustments. WARN & Co, incorporated on May 10, 2013, specializes in business transformation solutions for life sciences clients and reported an unaudited revenue of £2.5 million in its last financial year (May 1, 2024, to April 30, 2025).

The acquisition of WARN & Co is expected to be completed on or before October 17, 2025, and is not a related party transaction. This strategic acquisition enhances Indegene's ability to drive large-scale business transformations, complementing its organic growth and prior acquisition of DT Consulting in 2020.